TrialEndocrinology, diabetes & metabolism2026

Effects of SGLT-2 Inhibitors on Plasma Concentrations and Renal Clearance of the Risk Marker Trimethylamine-N-Oxide in Patients With Type-2 Diabetes.

Katja B Zimmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.